Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Clovis Oncology, Inc. (CLVS)

« Back to company index

CLVS Chatter Timeline

Stock Ticker for CLVS

Most Active Tweeters for CLVS

UserTweets
@Gambiste1 7
@Tickeron 4
@dellakwal 4
@JDR1024 4
@ConsumerFeed 3

Recent Tweets for CLVS

dellakwal @dellakwal
added shares at 5.30 today $CLVS
1:09pm
MasterTraderAle @MasterTraderAle
$CLVS decent size buys crossing
1:09pm
MasterTraderAle @MasterTraderAle
$CLVS 5.30s is bottom. See ya at $7s when the news out
11:09am
Gambiste1 @Gambiste1
RT @sunrgu: $CLVS short interest almost 21 million shares
12:09am
sunrgu @sunrgu
$CLVS short interest almost 21 million shares
September 15th 2019, 9:09pm
AmericanBanking @AmericanBanking
Clovis Oncology $CLVS Given Average Rating of “Hold” by Brokerages https://t.co/86UwM57zpy #stocks
September 15th 2019, 10:09am
WeekHerald @WeekHerald
Clovis Oncology $CLVS Given Average Rating of “Hold” by Brokerages https://t.co/lnlXXB0Wny
September 15th 2019, 10:09am
OlympiaReport @OlympiaReport
Clovis Oncology $CLVS Given Average Rating of “Hold” by Brokerages https://t.co/TKLz8moxZ7
September 15th 2019, 10:09am
dispatchtribune @dispatchtribune
Clovis Oncology $CLVS Given Average Rating of “Hold” by Brokerages https://t.co/qv5fFzPTuN
September 15th 2019, 10:09am
dispatchtribune @dispatchtribune
Clovis Oncology $CLVS Trading Down 5.3% https://t.co/phTmm3gUXH
September 14th 2019, 12:09pm
OlympiaReport @OlympiaReport
Clovis Oncology $CLVS Trading Down 5.3% https://t.co/Yze6P8Q3ds
September 14th 2019, 12:09pm
Tickeron @Tickeron
$CLVS's price moved below its 50-day Moving Average on March 22, 2019. View odds for this and other indicators:… https://t.co/gu5cZhLmXS
September 14th 2019, 5:09am
bbnsnews @bbnsnews
$36.31 Million in Sales Expected for Clovis Oncology $CLVS This Quarter https://t.co/FJJYIKtNoa
September 14th 2019, 2:09am
OlympiaReport @OlympiaReport
Zacks: Analysts Expect Clovis Oncology $CLVS Will Announce Earnings of -$1.87 Per Share https://t.co/btRbtmPtF7
September 14th 2019, 2:09am
ConsumerFeed @ConsumerFeed
Zacks: Analysts Expect Clovis Oncology $CLVS Will Announce Earnings of -$1.87 Per Share https://t.co/dNO774nUZo
September 14th 2019, 2:09am
Gambiste1 @Gambiste1
RT @TrendSpider: $CLVS Why waiting for a successful retest + go is important when trading down-channel breakouts... BTW this is a weekly ch…
September 14th 2019, 1:09am
TrendSpider @TrendSpider
$CLVS Why waiting for a successful retest + go is important when trading down-channel breakouts... BTW this is a we… https://t.co/A4EHP0w8Sq
September 13th 2019, 11:09pm
sunrgu @sunrgu
@semodough BMY can buy $CLVS for cheap and can get good ROI
September 13th 2019, 7:09pm
Tickeron @Tickeron
$CLVS in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on December 15, 2017. View odds for… https://t.co/JtYvAbIar6
September 13th 2019, 2:09am
ShafferBiotech @ShafferBiotech
@MSollender $CLVS comes to mind
September 12th 2019, 3:09pm
Gambiste1 @Gambiste1
RT @MaxD56808233: great news from $CLVS #ProstateCancerAwarenessMonth #ovariancancer Clovis Oncology to Highlight Expanded Data from Rubra…
September 12th 2019, 12:09pm
dellakwal @dellakwal
added a little more of $CLVS
September 12th 2019, 11:09am
MaxD56808233 @MaxD56808233
great news from $CLVS #ProstateCancerAwarenessMonth #ovariancancer Clovis Oncology to Highlight Expanded Data from… https://t.co/HKuJFc3Wek
September 12th 2019, 9:09am
Gambiste1 @Gambiste1
RT @JDR1024: @grassosteve Been some insider buying going on in an old friend of yours, $CLVS.
September 12th 2019, 8:09am
Gambiste1 @Gambiste1
RT @JDR1024: @ACInvestorBlog Giddy up, $CLVS!
September 12th 2019, 8:09am
JDR1024 @JDR1024
@grassosteve Been some insider buying going on in an old friend of yours, $CLVS.
September 12th 2019, 8:09am
JDR1024 @JDR1024
@ACInvestorBlog Giddy up, $CLVS!
September 12th 2019, 8:09am
dellakwal @dellakwal
Clovis Oncology to Highlight Expanded Data from Rubraca® (rucaparib) TRITON and ARIEL Clinical Pr... $clvs… https://t.co/b0LpN3SOdW
September 12th 2019, 5:09am
newswithvalue @newswithvalue
$CLVS: (rucaparib) TRITON and ARIEL Clinical Programs in Prostate and …: https://t.co/RsjdJ0Brw9
September 12th 2019, 4:09am
Tickeron @Tickeron
$CLVS in Downtrend: 50-day Moving Average moved below 200-day Moving Average on December 15, 2017. View odds for th… https://t.co/J34lZi5hJI
September 12th 2019, 3:09am
Gambiste1 @Gambiste1
RT @semodough: Sept. 29 – $CLVS – Rubraca (prostate cancer) Phase II data Updated TRITON2 trial data for Rubraca in mCRPC will be presented…
September 11th 2019, 9:09pm
ConsumerFeed @ConsumerFeed
Analysts Expect Clovis Oncology $CLVS Will Post Quarterly Sales of $36.31 Million https://t.co/hFACaR7P8Z
September 11th 2019, 9:09pm
AmericanBanking @AmericanBanking
RegeneRx Biopharmaceuticals $RGRX versus Clovis Oncology $CLVS Financial Analysis https://t.co/tqJaVa0rAL #stocks
September 11th 2019, 4:09pm
ConsumerFeed @ConsumerFeed
Clovis Oncology $CLVS vs. RegeneRx Biopharmaceuticals $RGRX Critical Analysis https://t.co/EUlQJjteHl
September 11th 2019, 4:09pm
JDR1024 @JDR1024
@ACInvestorBlog $CLVS under accumulation. More insider buys at $RKDA!
September 11th 2019, 3:09pm
MyFriendFate @MyFriendFate
$CLVS nice strength. I've got a big position at 5.95
September 11th 2019, 3:09pm
JDR1024 @JDR1024
@ACInvestorBlog $CLVS great price action yesterday with volume. Ready to break higher imo.
September 11th 2019, 2:09pm
dellakwal @dellakwal
bought 1k shares of $CLVS down 83% worse case goes to zero best case gets taken out if pipeline works .
September 11th 2019, 2:09pm
WhispererLoan @WhispererLoan
RT @ACInvestorBlog: $CLVS on my swing long list. Breakout watch over 6.16 https://t.co/AJQ68pkLLq
September 11th 2019, 7:09am
ACInvestorBlog @ACInvestorBlog
$CLVS on my swing long list. Breakout watch over 6.16 https://t.co/AJQ68pkLLq
September 11th 2019, 7:09am
Tickeron @Tickeron
$CLVS in Downtrend: 50-day Moving Average broke below 200-day Moving Average on December 15, 2017. View odds for th… https://t.co/fs6JJuHCbn
September 11th 2019, 3:09am
dailypoliticaln @dailypoliticaln
Clovis Oncology $CLVS Shares Up 13.4% https://t.co/Pgo8G3K9JX
September 10th 2019, 11:09pm
ZolmaxNews @ZolmaxNews
Clovis Oncology $CLVS Shares Up 13.4% https://t.co/ScnHGWyaqw
September 10th 2019, 11:09pm
semodough @semodough
Sept. 29 – $CLVS – Rubraca (prostate cancer) Phase II data Updated TRITON2 trial data for Rubraca in mCRPC will be… https://t.co/m7O2SWglFY
September 10th 2019, 9:09pm
BuyWrites @BuyWrites
Good day in the markets for me today. Oncology stocks $PBYI and $CLVS way up on no obvious news.
September 10th 2019, 5:09pm
Gambiste1 @Gambiste1
RT @biotechw2019: $CLVS a pincher continuation with SAR flipped ! 20 DMA support. open gap $8 https://t.co/cmfPqLvAZG
September 10th 2019, 5:09pm
danielccross @danielccross
Time for $CLVS to raise again??
September 10th 2019, 4:09pm
biotechw2019 @biotechw2019
$CLVS a pincher continuation with SAR flipped ! 20 DMA support. open gap $8 https://t.co/cmfPqLvAZG
September 10th 2019, 3:09pm
Stock_News_Now @Stock_News_Now
$CLVS: New SEC Filing for CLVS: Form SC 13G/A (No. 0001144204-19-044100): https://t.co/xcbL4LsaWT
September 10th 2019, 3:09pm
confcalltran @confcalltran
The Vanguard Group just provided an update on share ownership of Clovis Oncology https://t.co/clmbluj4pE $CLVS
September 10th 2019, 3:09pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.